Cargando…

Beyond the visual analog scale: results from a multimodal pain assessment pilot study in first‐degree relatives of patients with rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	McDougall, Cairistin, Wiens, Dana, Smolik, Irene, Lee, Yvonne C., El‐Gabalawy, Hani S., O'Neil, Liam J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746659/ https://www.ncbi.nlm.nih.gov/pubmed/36254818 http://dx.doi.org/10.1002/acr2.11497

Ejemplares similares

Increased frequency of TIGIT+ CD4 T Cell subset in autoantibody-positive first-degree relatives of patients with rheumatoid arthritis
por: Anaparti, Vidyanand, et al.
Publicado: (2022)

Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes
por: Anaparti, Vidyanand, et al.
Publicado: (2022)

Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects
por: Anaparti, Vidyanand, et al.
Publicado: (2017)

Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention
por: Maisha, Jeba Atkia, et al.
Publicado: (2023)

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
por: O’Neil, Liam J., et al.
Publicado: (2021)

Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis
por: Anaparti, Vidyanand, et al.
Publicado: (2019)

Serum proteomic networks associate with pre-clinical rheumatoid arthritis autoantibodies and longitudinal outcomes
por: O’Neil, Liam J., et al.
Publicado: (2022)

Disparities in rheumatoid arthritis outcomes for North American Indigenous populations
por: Hitchon, Carol A, et al.
Publicado: (2023)

Oxidation in rheumatoid arthritis
por: Hitchon, Carol A, et al.
Publicado: (2004)

The Synovium in Rheumatoid Arthritis
por: Hitchon, Carol A, et al.
Publicado: (2011)

Can Studying Genetically Predisposed Individuals Inform Prevention Strategies for RA?
por: Fowler-Woods, Amanda, et al.
Publicado: (2021)

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis
por: Klee, Gina, et al.
Publicado: (2021)

Reduced cognitive ability in people with rheumatoid arthritis compared with age-matched healthy controls
por: Gwinnutt, James M, et al.
Publicado: (2021)

Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid Arthritis
por: Alcaraz, María José, et al.
Publicado: (2022)

Time to Include Fine Specificity Anti‐Citrullinated Protein Antibodies in the Routine Diagnosis and Management of Rheumatoid Arthritis?
por: Schwenzer, Anja, et al.
Publicado: (2019)

Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefit
por: Ulijn, Evy, et al.
Publicado: (2022)

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs
por: Chen, Chieh-I, et al.
Publicado: (2018)

Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission
por: Hammer, Hilde Berner, et al.
Publicado: (2021)

Mindfulness-based stress reduction to improve depression, pain and high patient global assessment in controlled rheumatoid arthritis
por: Gaboury, Isabelle, et al.
Publicado: (2022)

Primary care challenges in diagnosing and referring patients with suspected rheumatoid arthritis: a national cross-sectional GP survey
por: Scott, Ian C, et al.
Publicado: (2018)

Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
por: Conaghan, Philip G, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)
por: Wong-Pack, Matthew, et al.
Publicado: (2023)

Use of rheumatoid arthritis impact of disease (RAID) in routine care; identification of DAS28 remission and unmet patient-reported outcomes
por: Mistry, Jatin, et al.
Publicado: (2020)

Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany
por: Tony, Hans-Peter, et al.
Publicado: (2022)

Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021)

Should quantitative assessment of rheumatoid arthritis include measures of joint damage and patient distress, in addition to measures of apparent inflammatory activity?
por: Pincus, Theodore, et al.
Publicado: (2022)

Rituximab, but not other biologics, impairs humoral immunity in patients with rheumatoid arthritis—a study using CoVariant protein arrays
por: Lin, Wei-Hsun, et al.
Publicado: (2023)

Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis
por: El-Gabalawy, Hani S, et al.
Publicado: (2004)

Why do we not have a cure for rheumatoid arthritis?
por: El-Gabalawy, Hani D, et al.
Publicado: (2002)

Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies
por: Bajetto, Adriana, et al.
Publicado: (2020)

Mesenchymal stem cells as a multimodal treatment for nervous system diseases
por: Badyra, Bogna, et al.
Publicado: (2020)

Videodermoscopy of Trichoteiromania: It is Beyond Broom Hairs
por: Ankad, Balachandra S., et al.
Publicado: (2022)

A multimodal antimicrobial stewardship intervention to improve antibiotic prescribing in patients with COVID-19
por: Anderson, Shaylee, et al.
Publicado: (2023)

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations
por: de Moel, Emma C., et al.
Publicado: (2023)

Role of Anti–Carbamylated Protein Antibodies Compared to Anti–Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First‐Degree Relatives, and Healthy Controls
por: Koppejan, H., et al.
Publicado: (2016)

Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis
por: O’Neil, Liam J., et al.
Publicado: (2020)

How to Effectively Support Patients with Rheumatic Conditions Now and Beyond COVID‐19
por: Décary, Simon, et al.
Publicado: (2020)

Duration of psoriatic arthritis as a risk factor for myocardial infarction
por: Egeberg, Alexander, et al.
Publicado: (2018)

N‐Linked Glycans in the Variable Domain of IgG Anti–Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis
por: Hafkenscheid, Lise, et al.
Publicado: (2019)

The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients
por: Dwivedi, Ravi C, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_beqbsil55dkddr6vbavegi5nri